Hadi Valadi, researcher at the Department of Rheumatology and Inflammation Research, is one of those receiving an industrial doctoral student with funding from the Swedish Foundation for Strategic Research (SSF). The research is carried out in collaboration with AstraZeneca and focuses on understanding the mechanisms that govern how cells transmit genetic signals (RNA) to each other using small endogenous particles known as extracellular vesicles (EVs) or exosomes. The granted project aims to develop an RNA delivery platform based on these extracellular vesicles. The goal is to use this platform to target the transport of drugs, such as mRNA, to specific organs.
Sahlgrenska akademins nyheter
En personlig död (A Personal Death) – a chance to win Björn Fagerberg’s new book
She is doing her residency in the US with a medical degree from Gothenburg
Alba Corell reports from a high-level brain tumor meeting
From South Africa to Sweden: Collaborative Research Efforts Improving Pregnant Women’s Health
Sara Bjursten and Anna Wenger are the recipients of the Assar Gabrielsson Prize 2024
A full day for PhD students focused on mental health
Kaj Blennow ranked highest in Sweden in neuroscience
Linda Wass is doing a postdoc at Stanford with ALF funding
Karin Nilsson wrote the Thesis of the Year at Sahlgrenska Academy in 2023
